What does Apotheek De Vrijheid do?

Apotheek De Vrijheid is a pharmacy in Arendonk. Public Limited, started on 19 June 1984, 1 establishment.

What is the address of Apotheek De Vrijheid?

The registered office of Apotheek De Vrijheid is located at Vrijheid 71, 2370 Arendonk.

Is Apotheek De Vrijheid still active?

Yes. According to the CBE (30 October 2026) Apotheek De Vrijheid is active, legal situation “Normale toestand”, started on 19 June 1984.

Is Apotheek De Vrijheid registered on Peppol?

Yes, Apotheek De Vrijheid is registered on the Peppol network with ID 0208:0426025384.

What is the enterprise number of Apotheek De Vrijheid?

The enterprise number of Apotheek De Vrijheid is BE0426025384.

When was Apotheek De Vrijheid founded?

Apotheek De Vrijheid was founded on 19 June 1984.

Who are the directors of Apotheek De Vrijheid?

According to the 2025 annual accounts, the directors of Apotheek De Vrijheid are: L-L Pharma BV.

Is Apotheek De Vrijheid a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 June 1984; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek De Vrijheid make in 2025?

Apotheek De Vrijheid posted a profit after taxes of € 113,390 in financial year 2025.

What is the revenue of Apotheek De Vrijheid?

As a small company, Apotheek De Vrijheid is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 228,466.

How much does an employee at Apotheek De Vrijheid earn?

The average wage cost per full-time employee at Apotheek De Vrijheid was € 43,600 in 2025: staff costs of € 69,722 for 1.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek De Vrijheid have?

According to the 2025 annual accounts, Apotheek De Vrijheid has 1.6 full-time equivalents (FTE).

Apotheek De Vrijheid (Public Limited) - Arendonk

Dossier Apotheek De Vrijheid, printed on 30 October 2026 from databakkes.be/en/0426025384/apotheek-de-vrijheid. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 2.8 to 1.6.

Financials

Financial year 2025

Apotheek De Vrijheid from Arendonk, company number BE0426025384, closed financial year 2025 with a result of € 113,390 after tax. For that financial year Apotheek De Vrijheid recorded a gross margin of € 228,466 and equity of € 115,949. Compared with financial year 2024, the result moved from € 109,280 to € 113,390. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Growing

€ 115,949

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 113,390

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 58,493

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 112,000 paid out

99 % of the profit went to the shareholders, mostly to L-LPHARMA (99 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.6

▼ 0.9 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 69,722

▼ 38% vs 2024

€ 43,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 339,938

▼ 10% vs 2024

€ 36,884 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 81,142

▲ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 16,593

▼ 17% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 277,525 Gross margin 2022: € 277,525 First fiscal year in the series	€ 283,275 Gross margin 2023: € 283,275 ▲ 2% vs 2022 (€ 277,525) Favourable step	€ 268,237 Gross margin 2024: € 268,237 ▼ 5% vs 2023 (€ 283,275) Unfavourable step	€ 228,466 Gross margin 2025: € 228,466 ▼ 15% vs 2024 (€ 268,237) Unfavourable step	▼ 15%
Profit after taxes	€ 75,193 Profit after taxes 2022: € 75,193 First fiscal year in the series	€ 59,010 Profit after taxes 2023: € 59,010 ▼ 22% vs 2022 (€ 75,193) Unfavourable step	€ 109,280 Profit after taxes 2024: € 109,280 ▲ 85% vs 2023 (€ 59,010) Favourable step	€ 113,390 Profit after taxes 2025: € 113,390 ▲ 4% vs 2024 (€ 109,280) Favourable step	▲ 4%
Equity	€ 113,270 Equity 2022: € 113,270 First fiscal year in the series	€ 113,280 Equity 2023: € 113,280 Unchanged (€ 113,270) Favourable step	€ 114,559 Equity 2024: € 114,559 ▲ 1% vs 2023 (€ 113,280) Favourable step	€ 115,949 Equity 2025: € 115,949 ▲ 1% vs 2024 (€ 114,559) Favourable step	▲ 1%
Total debts	€ 786,703 Total debts 2022: € 786,703 First fiscal year in the series	€ 658,566 Total debts 2023: € 658,566 ▼ 16% vs 2022 (€ 786,703) Favourable step	€ 625,661 Total debts 2024: € 625,661 ▼ 5% vs 2023 (€ 658,566) Favourable step	€ 628,285 Total debts 2025: € 628,285 Unchanged (€ 625,661) Unfavourable step
Cash	€ 161,340 Cash 2022: € 161,340 First fiscal year in the series	€ 87,093 Cash 2023: € 87,093 ▼ 46% vs 2022 (€ 161,340) Unfavourable step	€ 89,706 Cash 2024: € 89,706 ▲ 3% vs 2023 (€ 87,093) Favourable step	€ 58,493 Cash 2025: € 58,493 ▼ 35% vs 2024 (€ 89,706) Unfavourable step	▼ 35%
Land & buildings	€ 331,914 Land & buildings 2022: € 331,914 First fiscal year in the series	€ 305,738 Land & buildings 2023: € 305,738 ▼ 8% vs 2022 (€ 331,914) Unchanged	€ 283,317 Land & buildings 2024: € 283,317 ▼ 7% vs 2023 (€ 305,738) Unchanged	€ 260,901 Land & buildings 2025: € 260,901 ▼ 8% vs 2024 (€ 283,317) Unchanged	▼ 8%
Retained profit	€ 17,270 Retained profit 2022: € 17,270 First fiscal year in the series	€ 17,280 Retained profit 2023: € 17,280 Unchanged (€ 17,270) Favourable step	€ 18,559 Retained profit 2024: € 18,559 ▲ 7% vs 2023 (€ 17,280) Favourable step	€ 19,949 Retained profit 2025: € 19,949 ▲ 7% vs 2024 (€ 18,559) Favourable step	▲ 7%
Dividend	€ 75,000 Dividend 2022: € 75,000 First fiscal year in the series	€ 59,000 Dividend 2023: € 59,000 ▼ 21% vs 2022 (€ 75,000) Unchanged	€ 108,000 Dividend 2024: € 108,000 ▲ 83% vs 2023 (€ 59,000) Unchanged	€ 112,000 Dividend 2025: € 112,000 ▲ 4% vs 2024 (€ 108,000) Unchanged	▲ 4%
Bank debt	€ 496,549 Bank debt 2022: € 496,549 First fiscal year in the series	€ 411,805 Bank debt 2023: € 411,805 ▼ 17% vs 2022 (€ 496,549) Favourable step	€ 376,185 Bank debt 2024: € 376,185 ▼ 9% vs 2023 (€ 411,805) Favourable step	€ 339,938 Bank debt 2025: € 339,938 ▼ 10% vs 2024 (€ 376,185) Favourable step	▼ 10%
Balance sheet total	€ 899,973 Balance sheet total 2022: € 899,973 First fiscal year in the series	€ 771,846 Balance sheet total 2023: € 771,846 ▼ 14% vs 2022 (€ 899,973) Unchanged	€ 740,220 Balance sheet total 2024: € 740,220 ▼ 4% vs 2023 (€ 771,846) Unchanged	€ 744,234 Balance sheet total 2025: € 744,234 ▲ 1% vs 2024 (€ 740,220) Unchanged	▲ 1%
Employees (FTE)	-	2.8 Employees (FTE) 2023: 2.8 First fiscal year in the series	2.5 Employees (FTE) 2024: 2.5 ▼ 0.3 vs 2023 (2.8) Unchanged	1.6 Employees (FTE) 2025: 1.6 ▼ 0.9 vs 2024 (2.5) Unchanged	▼ 0.9

Key figures of Apotheek De Vrijheid, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek De Vrijheid?

What happened at Apotheek De Vrijheid in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 113,390 (▲ 4% vs 2024). Source: NBB ↗
2023 L-L Pharma BV became a director. NBB
Jun 19, 1984 New establishment in Arendonk. KBO
Jun 19, 1984 Start of the company according to the CBE. KBO

In short

From € 75,193 profit in 2022 to € 113,390 profit in 2025.

Paid € 8,750 in corporate taxes since 2022.

Best year ever: 2025, with € 113,390 profit.

On average € 142,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

L-LPHARMA 99%

The stake of L-LPHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek De Vrijheid

Behind Apotheek De Vrijheid is L-L Pharma BV. The shares are held by L-LPHARMA (99%).

Directors

According to the 2025 annual accounts

L-L Pharma BV

Director · represented by Lynn Leemans

since 2023

Shareholders

L-LPHARMA

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Vrijheid 71

2370 Arendonk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.025.384

VAT number

BE 0426.025.384

Registered office

Vrijheid 71, 2370 Arendonk

Names & denominations

Apotheek De Vrijheid

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

19 June 1984

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek De Vrijheid

Warning lights

Financials

What happened to Apotheek De Vrijheid?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions